435 related articles for article (PubMed ID: 34413281)
21. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
22. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment.
Cherico AS; Rizvi A; Jayakrishnan T; Mewawalla P
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35817492
[TBL] [Abstract][Full Text] [Related]
23. Thromboembolism and bleeding in systemic amyloidosis: a review.
Nicol M; Siguret V; Vergaro G; Aimo A; Emdin M; Dillinger JG; Baudet M; Cohen-Solal A; Villesuzanne C; Harel S; Royer B; Arnulf B; Logeart D
ESC Heart Fail; 2022 Feb; 9(1):11-20. PubMed ID: 34784656
[TBL] [Abstract][Full Text] [Related]
24. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
25. [AL amyloidosis-associated factor X deficiency].
Croles FN; Beerenhout CH; Mulder AB; Meijer K; Nijziel MR
Ned Tijdschr Geneeskd; 2014; 158(6):A6678. PubMed ID: 24495369
[TBL] [Abstract][Full Text] [Related]
26. Axillary Lymphadenopathy as an Initial Presentation of Systemic Amyloidosis: A Case Report and Literature Review.
Kumar S; Grell GR; Joseph G; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096221133191. PubMed ID: 36300416
[TBL] [Abstract][Full Text] [Related]
27. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.
Kikukawa Y; Yuki H; Hirata S; Ide K; Nakata H; Miyakawa T; Matsuno N; Nosaka K; Yonemura Y; Kawaguchi T; Hata H; Mitsuya H; Okuno Y
Int J Hematol; 2015 Feb; 101(2):133-9. PubMed ID: 25430082
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin Light Chain Amyloidosis Presenting as Inferior Vena Cava Thrombosis.
Axentiev A; Rozik M; Slama E; Setya V
Am Surg; 2023 Jun; 89(6):2788-2790. PubMed ID: 34743583
[TBL] [Abstract][Full Text] [Related]
29. Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab.
Rybinski B; Kocoglu M
Am J Case Rep; 2021 Aug; 22():e933241. PubMed ID: 34421115
[TBL] [Abstract][Full Text] [Related]
30. [Cardiac amyloidosis - important differential diagnosis in heart failure].
Morbach C; Steinhardt M; Störk S
Dtsch Med Wochenschr; 2022 Nov; 147(23):1522-1530. PubMed ID: 36384153
[TBL] [Abstract][Full Text] [Related]
31. Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis.
Zampiccoli E; Barthelmes J; Kreysing L; Nägele MP; Nebunu D; Haider T; von Eckardstein A; Gerber B; Schwotzer R; Ruschitzka F; Sudano I; Flammer AJ
ESC Heart Fail; 2022 Apr; 9(2):1186-1194. PubMed ID: 35060356
[TBL] [Abstract][Full Text] [Related]
32. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
Emori Y; Sakugawa M; Niiya K; Kiguchi T; Kojima K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Tanimoto M; Yamasaki R; Ohara N; Harada M
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):555-9. PubMed ID: 12192308
[TBL] [Abstract][Full Text] [Related]
33. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
34. Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report.
Augstburger E; Sahel JA; Audo I
BMC Ophthalmol; 2020 Feb; 20(1):59. PubMed ID: 32085748
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous bilateral peri-orbital purpura: an important clinical sign of primary systemic amyloidosis.
Beatty PE; Killion L; Mc Hugh J; Tobin AM
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795269
[TBL] [Abstract][Full Text] [Related]
36. The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.
Iwadate D; Hasegawa E; Hoshino J; Hayami N; Sumida K; Yamanouchi M; Sekine A; Kawada M; Hiramatsu R; Suwabe T; Sawa N; Yuasa M; Wake A; Fujii T; Ohashi K; Takaichi K; Ubara Y
Intern Med; 2018 Mar; 57(5):701-706. PubMed ID: 29093408
[TBL] [Abstract][Full Text] [Related]
37. Primary systemic amyloidosis presenting with advanced heart failure.
Mehta SK; Cogan J; Reimold SC; De Lemos JA
Cardiol Rev; 2003; 11(3):152-5. PubMed ID: 12705845
[TBL] [Abstract][Full Text] [Related]
38. Multiorgan involvement by amyloid light chain amyloidosis.
Li G; Han D; Wei S; Wang H; Chen L
J Int Med Res; 2019 Apr; 47(4):1778-1786. PubMed ID: 30803274
[TBL] [Abstract][Full Text] [Related]
39. Amyloid light-chain amyloidosis presenting as abdominal bloating: a case report.
Lee ASY; Lee DZQ; Vasanwala FF
J Med Case Rep; 2016 Mar; 10():68. PubMed ID: 27026530
[TBL] [Abstract][Full Text] [Related]
40. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]